No Data
GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Investors Are up 5.0% in the Past Week, but Earnings Have Declined Over the Last Five Years
Guangyuyuan Traditional Chinese Medicine Co., Ltd. Report for the third quarter of 2024
Guangyuyuan Chinese Herbal Medicine (600771.SH) released its performance for the first three quarters, with a net income of 70.9642 million yuan, a year-on-year decrease of 22.49%.
guangyuyuan Chinese herbal medicine (600771.SH) disclosed the third quarter report of 2024, the company achieved revenue in the first three quarters...
Guangyuyuan Chinese Herbal Medicine (600771.SH): The net income for the first three quarters was 70.9642 million yuan, a year-on-year decrease of 22.49%.
Guangyuyuan (600771.SH) announced its third quarter report for 2024 on October 25th, with the company's revenue for the first three quarters of the year at 0.894 billion yuan, a decrease of 7.93% year-on-year; net income attributable to shareholders of the listed company was 70.9642 million yuan, a decrease of 22.49% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 65.334 million yuan, a decrease of 18.13% year-on-year; basic earnings per share was 0.14 yuan.
Is GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Stock Price Struggling As A Result Of Its Mixed Financials?
Shareholder of Guangyuyuan (600771.SH) plans to increase shareholding by 50 million yuan to 0.1 billion yuan.
Guangyuyuan (600771.SH) announced on August 26, 2024 that its controlling shareholder, Hainan Shennong Technology Group,...
GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Delivers Shareholders Respectable 11% CAGR Over 3 Years, Surging 7.0% in the Last Week Alone
